|
1
|
Nacken W, Roth J, Sorg C and Kerkhoff C:
S100A9/S100A8: Myeloid representatives of the S100 protein family
as prominent players in innate immunity. Microsc Res Tech.
60:569–580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ehrchen JM, Sunderkötter C, Foell D, Vogl
T and Roth J: The endogenous Toll-like receptor 4 agonist
S100A8/S100A9 (calprotectin) as innate amplifier of infection,
autoimmunity, and cancer. J Leukoc Biol. 86:557–566. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Engel S, Schluesener H, Mittelbronn M,
Seid K, Adjodah D, Wehner HD and Meyermann R: Dynamics of
microglial activation after human traumatic brain injury are
revealed by delayed expression of macrophage-related proteins MRP8
and MRP14. Acta Neuropathol. 100:313–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shepherd CE, Goyette J, Utter V, Rahimi F,
Yang Z, Geczy CL and Halliday GM: Inflammatory S100A9 and S100A12
proteins in Alzheimer's disease. Neurobiol Aging. 27:1554–1563.
2006. View Article : Google Scholar
|
|
5
|
Ziegler G1, Prinz V, Albrecht MW,
Harhausen D, Khojasteh U, Nacken W, Endres M, Dirnagl U, Nietfeld W
and Trendelenburg G: Mrp-8 and -14 mediate CNS injury in focal
cerebral ischemia. Biochim Biophys Acta. 1792:1198–1204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vogl T, Tenbrock K, Ludwig S, Leukert N,
Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg
C, et al: Mrp8 and Mrp14 are endogenous activators of Toll-like
receptor 4, promoting lethal, endotoxin-induced shock. Nat Med.
13:1042–1049. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harja E, Bu DX, Hudson BI, Chang JS, Shen
X, Hallam K, Kalea AZ, Lu Y, Rosario RH, Oruganti S, et al:
Vascular and inflammatory stresses mediate atherosclerosis via RAGE
and its ligands in apoE−/− mice. J Clin Invest.
118:183–194. 2008. View
Article : Google Scholar
|
|
8
|
Björk P, Björk A, Vogl T, Stenström M,
Liberg D, Olsson A, Roth J, Ivars F and Leanderson T:
Identification of human S100A9 as a novel target for treatment of
autoimmune disease via binding to quinoline-3-carboxamides. PLoS
Biol. 7:e972009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hofmann MA, Drury S, Fu C, Qu W, Taguchi
A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, et al: RAGE
mediates a novel proinflammatory axis: A central cell surface
receptor for S100/calgranulin polypeptides. Cell. 97:889–901. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Donato R: Intracellular and extracellular
roles of S100 proteins. Microsc Res Tech. 60:540–551. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roth J, Vogl T, Sorg C and Sunderkötter C:
Phagocyte-specific S100 proteins: A novel group of proinflammatory
molecules. Trends Immunol. 24:155–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghavami S, Rashedi I, Dattilo BM, Eshraghi
M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C and Los M:
S100A8/A9 at low concentration promotes tumor cell growth via RAGE
ligation and MAP kinase-dependent pathway. J Leukoc Biol.
83:1484–1492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neumar RW, Nolan JP, Adrie C, Aibiki M,
Berg RA, Böttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC,
et al: Post-cardiac arrest syndrome: Epidemiology, pathophysiology,
treatment, and prognostication A consensus statement from the
International Liaison Committee on Resuscitation (American Heart
Association, Australian and New Zealand Council on Resuscitation,
European Resuscitation Council, Heart and Stroke Foundation of
Canada, InterAmerican Heart Foundation, Resuscitation Council of
Asia, and the Resuscitation Council of Southern Africa); the
American Heart Association Emergency Cardiovascular Care Committee;
the Council on Cardiovascular Surgery and Anesthesia; the Council
on Cardiopulmonary, Perioperative, and Critical Care; the Council
on Clinical Cardiology; and the Stroke Council. Circulation.
118:2452–2483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schiopu A and Cotoi OS: S100A8 and S100A9:
DAMPs at the crossroads between innate immunity, traditional risk
factors, and cardiovascular disease. Mediators Inflamm.
2013:8283542013. View Article : Google Scholar
|
|
15
|
Ryckman C, Vandal K, Rouleau P, Talbot M
and Tessier PA: Proinflammatory activities of S100: Proteins
S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and
adhesion. J Immunol. 170:3233–3242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Viemann D, Strey A, Janning A, Jurk K,
Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, et al:
Myeloid-related proteins 8 and 14 induce a specific inflammatory
response in human microvascular endothelial cells. Blood.
105:2955–2962. 2005. View Article : Google Scholar
|
|
17
|
Bierhaus A, Humpert PM, Morcos M, Wendt T,
Chavakis T, Arnold B, Stern DM and Nawroth PP: Understanding RAGE,
the receptor for advanced glycation end products. J Mol Med (Berl).
83:876–886. 2005. View Article : Google Scholar
|
|
18
|
Sunahori K, Yamamura M, Yamana J, Takasugi
K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S and Makino
H: The S100A8/A9 heterodimer amplifies proinflammatory cytokine
production by macrophages via activation of nuclear factor kappa B
and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Arthritis Res Ther. 8:R692006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyd JH, Kan B, Roberts H, Wang Y and
Walley KR: S100A8 and S100A9 mediate endotoxin-induced
cardiomyocyte dysfunction via the receptor for advanced glycation
end products. Circ Res. 102:1239–1246. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Turovskaya O, Foell D, Sinha P, Vogl T,
Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, et
al: RAGE, carboxylated glycans and S100A8/A9 play essential roles
in colitis-associated carcinogenesis. Carcinogenesis. 29:2035–2043.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Neill LA and Kaltschmidt C: NF-kappa B:
A crucial transcription factor for glial and neuronal cell
function. Trends Neurosci. 20:252–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mattson MP: NF-kappaB in the survival and
plasticity of neurons. Neurochem Res. 30:883–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu H, Li Z, Zhu X, Lin R and Chen L:
Salidroside reduces cell mobility via NF-kappa B and MAPK signaling
in LPS-induced BV2 microglial cells. Evid Based Complement Alternat
Med. 2014:3838212014. View Article : Google Scholar
|
|
24
|
Jeong YH, Kim Y, Song H, Chung YS, Park SB
and Kim HS: Anti-inflammatory effects of α-galactosylceramide
analogs in activated microglial: Involvement of the p38 MAPK
signaling pathway. PLoS One. 9:e870302014. View Article : Google Scholar
|
|
25
|
Yuan L, Wu Y, Ren X, Liu Q, Wang J and Liu
X: Isoorientin attenuates lipopolysaccharide-induced
proinflammatory responses through down-regulation of ROS-related
MAPK/NF-κB signaling pathway in BV-2 microglial. Mol Cell Biochem.
386:153–165. 2014. View Article : Google Scholar
|
|
26
|
Li L, Wu Y, Wang Y, Wu J, Song L, Xian W,
Yuan S, Pei L and Shang Y: Resolvin D1 promotes the
interleukin-4-induced alternative activation in BV-2 microglial
cells. J Neuroinflammation. 11:722014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manderson AP, Kay JG, Hammond LA, Brown DL
and Stow JL: Subcompartments of the macrophage recycling endosome
direct the differential secretion of IL-6 and TNFalpha. J Cell
Biol. 178:57–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu J, Qu C, Lu X and Zhang S: Activation
of microglial by histamine and substance P. Cell Physiol Biochem.
34:768–780. 2014. View Article : Google Scholar
|
|
29
|
Ehlermann P, Eggers K, Bierhaus A, Most P,
Weichenhan D, Greten J, Nawroth PP, Katus HA and Remppis A:
Increased proinflammatory endothelial response to S100A8/A9 after
preactivation through advanced glycation end products. Cardiovasc
Diabetol. 5:62006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ishihara K, Namura T, Murayama H, Arai S,
Totani M and Ikemoto M: Possibility of formation of the
S100A8/A9-proinflammatory cytokine complexes in vivo in acute
inflammation and their functional roles. Rinsho Byori. 57:324–331.
2009.In Japanese. PubMed/NCBI
|
|
31
|
Cesaro A, Anceriz N, Plante A, Pagé N,
Tardif MR and Tessier PA: An inflammation loop orchestrated by
S100A9 and calprotectin is critical for development of arthritis.
PLoS One. 7:e454782012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee Y, Jang S, Min JK, Lee K, Sohn KC, Lim
JS, Im M, Lee HE, Seo YJ, Kim CD, et al: S100A8 and S100A9 are
messengers in the crosstalk between epidermis and dermis modulating
a psoriatic milieu in human skin. Biochem Biophys Res Commun.
423:647–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chimenti MS, Ballanti E, Perricone C,
Cipriani P, Giacomelli R and Perricone R: Immunomodulation in
psoriatic arthritis: Focus on cellular and molecular pathways.
Autoimmun Rev. 12:599–606. 2013. View Article : Google Scholar
|
|
34
|
McColl BW, Allan SM and Rothwell NJ:
Systemic infection, inflammation and acute ischemic stroke.
Neuroscience. 158:1049–1061. 2009. View Article : Google Scholar
|
|
35
|
Aliprantis AO, Yang RB, Weiss DS, Godowski
P and Zychlinsky A: The apoptotic signaling pathway activated by
Toll-like receptor-2. EMBO J. 19:3325–3336. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karikó K, Weissman D and Welsh FA:
Inhibition of Toll-like receptor and cytokine signaling - a
unifying theme in ischemic tolerance. J Cereb Blood Flow Metab.
24:1288–1304. 2004. View Article : Google Scholar
|
|
37
|
Kielian T: Toll-like receptors in central
nervous system glial inflammation and homeostasis. J Neurosci Res.
83:711–730. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mishra BB, Mishra PK and Teale JM:
Expression and distribution of Toll-like receptors in the brain
during murine neurocysticercosis. J Neuroimmunol. 181:46–56. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lehnardt S, Massillon L, Follett P, Jensen
FE, Ratan R, Rosenberg PA, Volpe JJ and Vartanian T: Activation of
innate immunity in the CNS triggers neurodegeneration through a
Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA.
100:8514–8519. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kilic U, Kilic E, Matter CM, Bassetti CL
and Hermann DM: TLR-4 deficiency protects against focal cerebral
ischemia and axotomy- induced neurodegeneration. Neurobiol Dis.
31:33–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marsh BJ, Williams-Karnesky RL and
Stenzel-Poore MP: Toll-like receptor signaling in endogenous
neuroprotection and stroke. Neuroscience. 158:1007–1020. 2009.
View Article : Google Scholar :
|
|
42
|
Heizmann CW, Ackermann GE and Galichet A:
Pathologies involving the S100 proteins and RAGE. Subcell Biochem.
45:93–138. 2007. View Article : Google Scholar
|
|
43
|
Hermani A, De Servi B, Medunjanin S,
Tessier PA and Mayer D: S100A8 and S100A9 activate MAP kinase and
NF-kappaB signaling pathways and trigger translocation of RAGE in
human prostate cancer cells. Exp Cell Res. 312:184–197. 2006.
View Article : Google Scholar
|
|
44
|
Eggers K, Sikora K, Lorenz M, Taubert T,
Moobed M, Baumann G, Stangl K and Stangl V: RAGE-dependent
regulation of calcium-binding proteins S100A8 and S100A9 in human
THP-1. Exp Clin Endocrinol Diabetes. 119:353–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fisher CJ Jr, Agosti JM, Opal SM, Lowry
SF, Balk RA, Sadoff JC, Abraham E, Schein RM and Benjamin E:
Treatment of septic shock with the tumor necrosis factor
receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study
Group. N Engl J Med. 334:1697–1702. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Clark MA, Plank LD, Connolly AB, Streat
SJ, Hill AA, Gupta R, Monk DN, Shenkin A and Hill GL: Effect of a
chimeric antibody to tumor necrosis factor-alpha on cytokine and
physiologic responses in patients with severe sepsis - a
randomized, clinical trial. Crit Care Med. 26:1650–1659. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rammes A, Roth J, Goebeler M, Klempt M,
Hartmann M and Sorg C: Myeloid-related protein (MRP) 8 and MRP14,
calcium-binding proteins of the S100 family, are secreted by
activated monocytes via a novel, tubulin-dependent pathway. J Biol
Chem. 272:9496–9502. 1997. View Article : Google Scholar : PubMed/NCBI
|
